financetom
Business
financetom
/
Business
/
QuidelOrtho Q1 Adjusted Earnings Rise, Revenue Falls; Fiscal 2025 Guidance Maintained
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
QuidelOrtho Q1 Adjusted Earnings Rise, Revenue Falls; Fiscal 2025 Guidance Maintained
May 26, 2025 3:50 AM

04:41 AM EDT, 05/08/2025 (MT Newswires) -- QuidelOrtho ( QDEL ) reported Q1 adjusted earnings late Wednesday of $0.74 per diluted share, up from $0.44 a year earlier.

Analysts polled by FactSet expected $0.59.

Revenue for the quarter ended March 30 was $692.8 million, compared with $711 million a year earlier.

Analysts surveyed by FactSet expected $689.6 million.

The company maintained its fiscal 2025 adjusted earnings guidance of $2.07 to $2.57 per diluted share on revenue of $2.60 billion to $2.81 billion. Analysts surveyed by FactSet expect adjusted earnings of $2.36 per share on revenue of $2.70 billion.

Shares were up more than 7% in recent premarket activity Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Drugmakers will ask US government to pause drug price negotiations, Bloomberg News reports
Drugmakers will ask US government to pause drug price negotiations, Bloomberg News reports
Jan 14, 2025
Jan 13 (Reuters) - Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday, citing Eli Lilly's ( LLY ) CEO David Ricks. Ricks said at the JPMorgan Healthcare Conference that the government needs to fix the Inflation Reduction Act (IRA) before the second round of talks over price cuts, the report...
Drugmakers will ask US government to pause drug price negotiations, Bloomberg News reports
Drugmakers will ask US government to pause drug price negotiations, Bloomberg News reports
Jan 14, 2025
((This Jan. 13 story has been corrected to say 'drugmakers will ask,' not 'Eli Lilly ( LLY ) has asked' to pause negotiations, after the company clarified, in the headline & paragraph 1)) (Reuters) - Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday, citing Eli Lilly's ( LLY ) CEO...
Oil shipping rates surge after US sanctions hit availability
Oil shipping rates surge after US sanctions hit availability
Jan 14, 2025
* VLCC rates for Mideast to China up 39% since Friday * Shipping costs for Russian ESPO Blend to China more than double - S&P Global * Fleet tightness could worsen if shadow fleet seeks new vessels - Kpler (Updates with new tanker bookings, crude prices in paragraphs 9-11) By Florence Tan and Siyi Liu SINGAPORE, Jan 14 (Reuters) -...
B2Gold Cuts Dividend, Plans Normal Course Issuer Bid as Part of Amended Shareholder Returns Strategy
B2Gold Cuts Dividend, Plans Normal Course Issuer Bid as Part of Amended Shareholder Returns Strategy
Jan 14, 2025
06:00 AM EST, 01/14/2025 (MT Newswires) -- B2Gold ( BTG ) late on Monday amended its shareholder returns strategy to boost financial flexibility, including a decrease in its quarterly dividend. The company cut the quarterly dividend to US$0.02 per common share from US$0.04. B2Gold ( BTG ) is currently focused on completing construction of the Goose mine, advancing development of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved